

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vitamin transmembrane transport (GO:0035461) | 8.84495261 |
| 2 | desmosome organization (GO:0002934) | 7.29165480 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.31129988 |
| 4 | bile acid and bile salt transport (GO:0015721) | 5.95274150 |
| 5 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.85459177 |
| 6 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.85459177 |
| 7 | intestinal absorption (GO:0050892) | 5.72252828 |
| 8 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.25994826 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 5.23719688 |
| 10 | cytidine metabolic process (GO:0046087) | 5.00213569 |
| 11 | cytidine catabolic process (GO:0006216) | 5.00213569 |
| 12 | cytidine deamination (GO:0009972) | 5.00213569 |
| 13 | drug catabolic process (GO:0042737) | 4.94508391 |
| 14 | macrophage chemotaxis (GO:0048246) | 4.92537966 |
| 15 | regulation of guanylate cyclase activity (GO:0031282) | 4.89063917 |
| 16 | positive regulation of fatty acid oxidation (GO:0046321) | 4.87522503 |
| 17 | flavonoid metabolic process (GO:0009812) | 4.79418829 |
| 18 | actin filament depolymerization (GO:0030042) | 4.75748503 |
| 19 | exogenous drug catabolic process (GO:0042738) | 4.62926632 |
| 20 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.62785950 |
| 21 | sulfur compound transport (GO:0072348) | 4.56159946 |
| 22 | cellular glucuronidation (GO:0052695) | 4.51108398 |
| 23 | primary alcohol catabolic process (GO:0034310) | 4.46530308 |
| 24 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.42213552 |
| 25 | intestinal cholesterol absorption (GO:0030299) | 4.36955392 |
| 26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.33667816 |
| 27 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.33556453 |
| 28 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.33556453 |
| 29 | endocrine process (GO:0050886) | 4.33556453 |
| 30 | regulation of cGMP biosynthetic process (GO:0030826) | 4.29416066 |
| 31 | epithelial structure maintenance (GO:0010669) | 4.27885624 |
| 32 | angiotensin maturation (GO:0002003) | 4.27304757 |
| 33 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.15953950 |
| 34 | ethanol metabolic process (GO:0006067) | 4.13794586 |
| 35 | galactose catabolic process (GO:0019388) | 4.12858187 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 4.11370186 |
| 37 | azole transport (GO:0045117) | 4.11136106 |
| 38 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.10449741 |
| 39 | uronic acid metabolic process (GO:0006063) | 4.00777439 |
| 40 | glucuronate metabolic process (GO:0019585) | 4.00777439 |
| 41 | lipoprotein metabolic process (GO:0042157) | 3.98038487 |
| 42 | nitric oxide metabolic process (GO:0046209) | 3.95073357 |
| 43 | hypotonic response (GO:0006971) | 3.92440251 |
| 44 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.89067647 |
| 45 | artery smooth muscle contraction (GO:0014824) | 3.88238132 |
| 46 | morphogenesis of an epithelial fold (GO:0060571) | 3.85951210 |
| 47 | fucose catabolic process (GO:0019317) | 3.85900037 |
| 48 | L-fucose metabolic process (GO:0042354) | 3.85900037 |
| 49 | L-fucose catabolic process (GO:0042355) | 3.85900037 |
| 50 | positive regulation of lipid catabolic process (GO:0050996) | 3.82154728 |
| 51 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.78093382 |
| 52 | sulfate transmembrane transport (GO:1902358) | 3.77883122 |
| 53 | regulation of cholesterol metabolic process (GO:0090181) | 3.77667144 |
| 54 | bicarbonate transport (GO:0015701) | 3.67403970 |
| 55 | regulation of vitamin metabolic process (GO:0030656) | 3.66797672 |
| 56 | regulation of systemic arterial blood pressure (GO:0003073) | 3.66397092 |
| 57 | artery development (GO:0060840) | 3.63390866 |
| 58 | vitamin transport (GO:0051180) | 3.61818363 |
| 59 | positive regulation of cGMP metabolic process (GO:0030825) | 3.61013338 |
| 60 | vitamin A metabolic process (GO:0006776) | 3.59504005 |
| 61 | regulation of cGMP metabolic process (GO:0030823) | 3.59049077 |
| 62 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.58512190 |
| 63 | urate metabolic process (GO:0046415) | 3.57391385 |
| 64 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.54385761 |
| 65 | digestive system process (GO:0022600) | 3.52243801 |
| 66 | renal system process involved in regulation of blood volume (GO:0001977) | 3.51834146 |
| 67 | homocysteine metabolic process (GO:0050667) | 3.50429245 |
| 68 | phospholipid efflux (GO:0033700) | 3.50421109 |
| 69 | NADH metabolic process (GO:0006734) | 3.43481632 |
| 70 | intermediate filament organization (GO:0045109) | 3.40518935 |
| 71 | fucosylation (GO:0036065) | 3.39389813 |
| 72 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.37927041 |
| 73 | glycerol metabolic process (GO:0006071) | 3.35933218 |
| 74 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.33804083 |
| 75 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.32681079 |
| 76 | regulation of interleukin-1 secretion (GO:0050704) | 3.32040180 |
| 77 | cellular ketone body metabolic process (GO:0046950) | 3.31013167 |
| 78 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.30941122 |
| 79 | intestinal epithelial cell development (GO:0060576) | 3.30643276 |
| 80 | xenobiotic catabolic process (GO:0042178) | 3.30392240 |
| 81 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.30116824 |
| 82 | tonic smooth muscle contraction (GO:0014820) | 3.27981287 |
| 83 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.26481517 |
| 84 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.25028744 |
| 85 | viral transcription (GO:0019083) | 3.24732254 |
| 86 | adhesion of symbiont to host cell (GO:0044650) | 3.24680848 |
| 87 | virion attachment to host cell (GO:0019062) | 3.24680848 |
| 88 | alkaloid metabolic process (GO:0009820) | 3.22774893 |
| 89 | GDP-mannose metabolic process (GO:0019673) | 3.22655371 |
| 90 | sperm capacitation (GO:0048240) | 3.19190528 |
| 91 | digestion (GO:0007586) | 3.15986368 |
| 92 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.13898206 |
| 93 | eosinophil chemotaxis (GO:0048245) | 3.13148135 |
| 94 | hormone catabolic process (GO:0042447) | 3.12881895 |
| 95 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.11935456 |
| 96 | sulfate transport (GO:0008272) | 3.11019460 |
| 97 | positive regulation of pseudopodium assembly (GO:0031274) | 3.10281849 |
| 98 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.09665605 |
| 99 | sodium ion homeostasis (GO:0055078) | 3.09002137 |
| 100 | diacylglycerol metabolic process (GO:0046339) | 3.08081669 |
| 101 | citrulline biosynthetic process (GO:0019240) | 3.07852796 |
| 102 | regulation of bile acid biosynthetic process (GO:0070857) | 3.03831380 |
| 103 | nitric oxide biosynthetic process (GO:0006809) | 3.03771865 |
| 104 | translational termination (GO:0006415) | 3.03597413 |
| 105 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.03346021 |
| 106 | sulfation (GO:0051923) | 3.02073979 |
| 107 | tight junction assembly (GO:0070830) | 3.01705380 |
| 108 | alditol metabolic process (GO:0019400) | 2.98154519 |
| 109 | hemidesmosome assembly (GO:0031581) | 2.95154267 |
| 110 | protein autoprocessing (GO:0016540) | 2.93686110 |
| 111 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.93245902 |
| 112 | negative regulation of protein autophosphorylation (GO:0031953) | 2.91625380 |
| 113 | fucose metabolic process (GO:0006004) | 2.90625540 |
| 114 | prostanoid metabolic process (GO:0006692) | 2.90341449 |
| 115 | prostaglandin metabolic process (GO:0006693) | 2.90341449 |
| 116 | O-glycan processing (GO:0016266) | 2.90334110 |
| 117 | urea metabolic process (GO:0019627) | 2.90292915 |
| 118 | hepatocyte apoptotic process (GO:0097284) | 2.89796363 |
| 119 | regulation of histone phosphorylation (GO:0033127) | 2.89033020 |
| 120 | ethanol oxidation (GO:0006069) | 2.88667061 |
| 121 | oligosaccharide biosynthetic process (GO:0009312) | 2.88598057 |
| 122 | inositol phosphate-mediated signaling (GO:0048016) | 2.86108378 |
| 123 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.83312274 |
| 124 | regulation of metalloenzyme activity (GO:0048552) | 2.83171273 |
| 125 | transcytosis (GO:0045056) | 2.83169500 |
| 126 | regulation of cellular extravasation (GO:0002691) | 2.83131949 |
| 127 | cell communication involved in cardiac conduction (GO:0086065) | 2.83131811 |
| 128 | ketone body metabolic process (GO:1902224) | 2.82809467 |
| 129 | regulation of early endosome to late endosome transport (GO:2000641) | 2.81911642 |
| 130 | urea cycle (GO:0000050) | 2.81806284 |
| 131 | lipoprotein transport (GO:0042953) | 2.81618457 |
| 132 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.79260157 |
| 133 | eosinophil migration (GO:0072677) | 2.78982889 |
| 134 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.78720198 |
| 135 | response to hepatocyte growth factor (GO:0035728) | 2.78425381 |
| 136 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.78425381 |
| 137 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.77935125 |
| 138 | quinone biosynthetic process (GO:1901663) | 2.75909063 |
| 139 | ubiquinone biosynthetic process (GO:0006744) | 2.75909063 |
| 140 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.75444390 |
| 141 | glycolipid catabolic process (GO:0019377) | 2.74907453 |
| 142 | regulation of respiratory burst (GO:0060263) | 2.74885493 |
| 143 | antibacterial humoral response (GO:0019731) | 2.73189143 |
| 144 | regulation of nitric-oxide synthase activity (GO:0050999) | 2.73045232 |
| 145 | drug transmembrane transport (GO:0006855) | 2.72757449 |
| 146 | drug metabolic process (GO:0017144) | 2.71022584 |
| 147 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.70781112 |
| 148 | regulation of cholesterol homeostasis (GO:2000188) | 2.70741903 |
| 149 | regulation of pseudopodium assembly (GO:0031272) | 2.70650952 |
| 150 | response to histamine (GO:0034776) | 2.70563421 |
| 151 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.70000244 |
| 152 | regulation of triglyceride catabolic process (GO:0010896) | 2.69860851 |
| 153 | DNA damage induced protein phosphorylation (GO:0006975) | 2.69813885 |
| 154 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.68203762 |
| 155 | antimicrobial humoral response (GO:0019730) | 2.66745796 |
| 156 | thrombin receptor signaling pathway (GO:0070493) | 2.66204673 |
| 157 | cyclooxygenase pathway (GO:0019371) | 2.65931626 |
| 158 | regulation of RIG-I signaling pathway (GO:0039535) | 2.64270355 |
| 159 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.63476893 |
| 160 | protein targeting to ER (GO:0045047) | 2.63298608 |
| 161 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.62053645 |
| 162 | adhesion of symbiont to host (GO:0044406) | 2.61531987 |
| 163 | cotranslational protein targeting to membrane (GO:0006613) | 2.61493038 |
| 164 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.60847643 |
| 165 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.60847643 |
| 166 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 10.1363897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.76980966 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.95009466 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.67996283 |
| 4 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.28450104 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.28297481 |
| 6 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.21020338 |
| 7 | * SOX2_20726797_ChIP-Seq_SW620_Human | 3.10614986 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97344438 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.91986000 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.86684355 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.82355157 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.71934046 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55849148 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.54410373 |
| 15 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.43134130 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42959215 |
| 17 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.20258104 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14036373 |
| 19 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.11596951 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95759681 |
| 21 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.83611451 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.83418570 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81274329 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80468457 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79296484 |
| 26 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.75978779 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67283728 |
| 28 | ATF3_27146783_Chip-Seq_COLON_Human | 1.66106300 |
| 29 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65253227 |
| 30 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.62781599 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62001885 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60408009 |
| 33 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.59624862 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57956144 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57872478 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.57831685 |
| 37 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.56956815 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52815746 |
| 39 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.52556980 |
| 40 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.52264267 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49958535 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47221649 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44648652 |
| 44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44625681 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43164921 |
| 46 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43061159 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40463029 |
| 48 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38303155 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.37058116 |
| 50 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35609951 |
| 51 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35484216 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.34664061 |
| 53 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.31974053 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30251900 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28894536 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27448884 |
| 57 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23337558 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23104421 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23104421 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22199892 |
| 61 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19008050 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17780915 |
| 63 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.17296727 |
| 64 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16807820 |
| 65 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14784183 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11776558 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11377046 |
| 68 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11209169 |
| 69 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11209169 |
| 70 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.08245412 |
| 71 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07917334 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05882731 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04290731 |
| 74 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04257721 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02569549 |
| 76 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01955905 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00847279 |
| 78 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.99785116 |
| 79 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97796164 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97669036 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96762053 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95884966 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95089770 |
| 84 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94293564 |
| 85 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93542649 |
| 86 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93528217 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92897032 |
| 88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92624621 |
| 89 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.91534050 |
| 90 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.91348600 |
| 91 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91312111 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91145785 |
| 93 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.90923053 |
| 94 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.90782002 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90347830 |
| 96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89488851 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89452199 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88960719 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88508546 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88324029 |
| 101 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87584148 |
| 102 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87152630 |
| 103 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86722249 |
| 104 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86648843 |
| 105 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.86457603 |
| 106 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85971218 |
| 107 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85794957 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84874353 |
| 109 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84595372 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84436958 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84009417 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83986078 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83953566 |
| 114 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.83889890 |
| 115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.83534933 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82775962 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81804334 |
| 118 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81787571 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81578984 |
| 120 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.81473004 |
| 121 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.81332490 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80927040 |
| 123 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80282386 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 0.79898510 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79708054 |
| 126 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.79075800 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78872554 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78290073 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78239735 |
| 130 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.78150214 |
| 131 | VDR_22108803_ChIP-Seq_LS180_Human | 0.77716403 |
| 132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77128375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005377_hearing/vestibular/ear_phenot | 4.47605165 |
| 2 | MP0003878_abnormal_ear_physiology | 4.47605165 |
| 3 | MP0002822_catalepsy | 4.42003381 |
| 4 | MP0001873_stomach_inflammation | 3.88540652 |
| 5 | MP0008004_abnormal_stomach_pH | 3.51459254 |
| 6 | MP0005360_urolithiasis | 3.36714482 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.17047656 |
| 8 | MP0003866_abnormal_defecation | 3.12478787 |
| 9 | MP0000462_abnormal_digestive_system | 2.82339709 |
| 10 | MP0001663_abnormal_digestive_system | 2.71544546 |
| 11 | MP0001664_abnormal_digestion | 2.65295345 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.61585399 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.59277493 |
| 14 | MP0005381_digestive/alimentary_phenotyp | 2.51108294 |
| 15 | MP0004264_abnormal_extraembryonic_tissu | 2.39861490 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.38274123 |
| 17 | MP0004147_increased_porphyrin_level | 2.25524917 |
| 18 | MP0005670_abnormal_white_adipose | 2.25410756 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.25183004 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.24978463 |
| 21 | MP0003303_peritoneal_inflammation | 2.23234336 |
| 22 | MP0010678_abnormal_skin_adnexa | 2.03300505 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 10.1424583 |
| 24 | MP0003252_abnormal_bile_duct | 1.82911437 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.82546528 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.81919781 |
| 27 | MP0000490_abnormal_crypts_of | 1.79122829 |
| 28 | MP0000477_abnormal_intestine_morphology | 1.78453348 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.74078517 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.67421238 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.66461415 |
| 32 | MP0002796_impaired_skin_barrier | 1.59630220 |
| 33 | MP0005367_renal/urinary_system_phenotyp | 1.55476486 |
| 34 | MP0000516_abnormal_urinary_system | 1.55476486 |
| 35 | MP0010329_abnormal_lipoprotein_level | 1.51663729 |
| 36 | MP0009785_altered_susceptibility_to | 1.47698771 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.46832203 |
| 38 | MP0000470_abnormal_stomach_morphology | 1.46421698 |
| 39 | MP0001756_abnormal_urination | 1.42366904 |
| 40 | MP0000383_abnormal_hair_follicle | 1.42273155 |
| 41 | MP0001764_abnormal_homeostasis | 1.33579557 |
| 42 | MP0001188_hyperpigmentation | 1.29955179 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.28920913 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.28328722 |
| 45 | MP0009840_abnormal_foam_cell | 1.26900995 |
| 46 | MP0002132_abnormal_respiratory_system | 1.25226356 |
| 47 | MP0003941_abnormal_skin_development | 1.24856623 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.23698309 |
| 49 | MP0008872_abnormal_physiological_respon | 1.22681633 |
| 50 | MP0005408_hypopigmentation | 1.22500149 |
| 51 | MP0000685_abnormal_immune_system | 1.20269888 |
| 52 | MP0003868_abnormal_feces_composition | 1.16930892 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.13649951 |
| 54 | MP0003186_abnormal_redox_activity | 1.10926494 |
| 55 | MP0003315_abnormal_perineum_morphology | 1.09115416 |
| 56 | MP0002234_abnormal_pharynx_morphology | 1.09103416 |
| 57 | MP0004947_skin_inflammation | 1.06018276 |
| 58 | MP0005166_decreased_susceptibility_to | 1.05644770 |
| 59 | MP0002971_abnormal_brown_adipose | 1.05514302 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.01399745 |
| 61 | MP0003879_abnormal_hair_cell | 1.00907868 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 1.00886701 |
| 63 | MP0003693_abnormal_embryo_hatching | 0.94803481 |
| 64 | MP0006082_CNS_inflammation | 0.94212565 |
| 65 | MP0005165_increased_susceptibility_to | 0.93320291 |
| 66 | MP0000566_synostosis | 0.92749039 |
| 67 | MP0004885_abnormal_endolymph | 0.90685876 |
| 68 | MP0009643_abnormal_urine_homeostasis | 0.90677315 |
| 69 | MP0000230_abnormal_systemic_arterial | 0.88704449 |
| 70 | MP0003718_maternal_effect | 0.85237741 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 0.85149103 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 0.85073466 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 0.81405898 |
| 74 | MP0002060_abnormal_skin_morphology | 0.81018203 |
| 75 | MP0005501_abnormal_skin_physiology | 0.80602228 |
| 76 | MP0001216_abnormal_epidermal_layer | 0.78791620 |
| 77 | MP0008260_abnormal_autophagy | 0.78490331 |
| 78 | MP0005365_abnormal_bile_salt | 0.78293835 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.78213746 |
| 80 | MP0003385_abnormal_body_wall | 0.77613452 |
| 81 | MP0009115_abnormal_fat_cell | 0.76065825 |
| 82 | MP0000858_altered_metastatic_potential | 0.75679198 |
| 83 | MP0004043_abnormal_pH_regulation | 0.74398103 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.73316245 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.73211533 |
| 86 | MP0000467_abnormal_esophagus_morphology | 0.72843286 |
| 87 | MP0005023_abnormal_wound_healing | 0.72796044 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.72624438 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.72381614 |
| 90 | MP0008873_increased_physiological_sensi | 0.72330673 |
| 91 | MP0005083_abnormal_biliary_tract | 0.69399795 |
| 92 | MP0003724_increased_susceptibility_to | 0.69356000 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.68400330 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.68083229 |
| 95 | MP0002254_reproductive_system_inflammat | 0.67608455 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.67228321 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.66505514 |
| 98 | MP0001485_abnormal_pinna_reflex | 0.65996848 |
| 99 | MP0000249_abnormal_blood_vessel | 0.64622537 |
| 100 | MP0001849_ear_inflammation | 0.63660102 |
| 101 | MP0000613_abnormal_salivary_gland | 0.63085919 |
| 102 | MP0001881_abnormal_mammary_gland | 0.62953851 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.62894703 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.60792239 |
| 105 | MP0000537_abnormal_urethra_morphology | 0.60704801 |
| 106 | MP0009379_abnormal_foot_pigmentation | 0.60548645 |
| 107 | MP0003283_abnormal_digestive_organ | 0.58921444 |
| 108 | MP0000609_abnormal_liver_physiology | 0.58276251 |
| 109 | MP0008469_abnormal_protein_level | 0.57217216 |
| 110 | MP0010771_integument_phenotype | 0.56650631 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.55183072 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.54739785 |
| 113 | MP0005332_abnormal_amino_acid | 0.53879119 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.53727330 |
| 115 | MP0000013_abnormal_adipose_tissue | 0.52983830 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.52632189 |
| 117 | MP0005410_abnormal_fertilization | 0.52258006 |
| 118 | MP0009053_abnormal_anal_canal | 0.48817745 |
| 119 | MP0005025_abnormal_response_to | 0.47475745 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.45599929 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.44716120 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.44463983 |
| 123 | MP0000678_abnormal_parathyroid_gland | 0.43838973 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.41258960 |
| 125 | MP0009780_abnormal_chondrocyte_physiolo | 0.39702462 |
| 126 | MP0001440_abnormal_grooming_behavior | 0.39023716 |
| 127 | MP0005448_abnormal_energy_balance | 0.38285295 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.38265646 |
| 129 | MP0005266_abnormal_metabolism | 0.37454467 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.36377161 |
| 131 | MP0005319_abnormal_enzyme/_coenzyme | 0.36299455 |
| 132 | MP0001270_distended_abdomen | 0.35676023 |
| 133 | MP0009642_abnormal_blood_homeostasis | 0.34590192 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.34544813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malnutrition (HP:0004395) | 7.81547838 |
| 2 | Flat acetabular roof (HP:0003180) | 6.67703686 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 6.63400805 |
| 4 | Abnormality of small intestinal villus morphology (HP:0011472) | 6.28449125 |
| 5 | Villous atrophy (HP:0011473) | 6.28449125 |
| 6 | Ileus (HP:0002595) | 5.28826808 |
| 7 | Pigmentary retinal degeneration (HP:0001146) | 5.19797170 |
| 8 | Abdominal distention (HP:0003270) | 4.90165671 |
| 9 | Cupped ribs (HP:0000887) | 4.68123632 |
| 10 | Abnormal tarsal ossification (HP:0008369) | 4.62758744 |
| 11 | Prostate neoplasm (HP:0100787) | 4.46229866 |
| 12 | Woolly hair (HP:0002224) | 4.34616127 |
| 13 | Gout (HP:0001997) | 4.20012557 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 4.11112224 |
| 15 | Chorioretinal atrophy (HP:0000533) | 4.09207439 |
| 16 | Oligomenorrhea (HP:0000876) | 3.78920659 |
| 17 | Pustule (HP:0200039) | 3.78846223 |
| 18 | Fragile nails (HP:0001808) | 3.55426358 |
| 19 | Alopecia of scalp (HP:0002293) | 3.55166405 |
| 20 | Vascular calcification (HP:0004934) | 3.50898983 |
| 21 | Abnormality of chloride homeostasis (HP:0011422) | 3.36591678 |
| 22 | Congenital sensorineural hearing impairment (HP:0008527) | 3.31092133 |
| 23 | Dehydration (HP:0001944) | 3.26811538 |
| 24 | Xanthomatosis (HP:0000991) | 3.23226944 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.20581804 |
| 26 | Steatorrhea (HP:0002570) | 3.20245513 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.19194425 |
| 28 | Abnormal foot bone ossification (HP:0010675) | 3.15082668 |
| 29 | Decreased circulating renin level (HP:0003351) | 3.14961581 |
| 30 | Metabolic alkalosis (HP:0200114) | 3.11343517 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 3.00367316 |
| 32 | Hypolipoproteinemia (HP:0010981) | 2.99145575 |
| 33 | Cardiovascular calcification (HP:0011915) | 2.96390642 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 2.89445373 |
| 35 | Hyperammonemia (HP:0001987) | 2.89012367 |
| 36 | Palpitations (HP:0001962) | 2.87711634 |
| 37 | Hyperglycinuria (HP:0003108) | 2.79789520 |
| 38 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.78137311 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.77295329 |
| 40 | Macrocytic anemia (HP:0001972) | 2.76737006 |
| 41 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.75580225 |
| 42 | Congenital stationary night blindness (HP:0007642) | 2.67518227 |
| 43 | Facial shape deformation (HP:0011334) | 2.67357923 |
| 44 | Potter facies (HP:0002009) | 2.67357923 |
| 45 | Focal segmental glomerulosclerosis (HP:0000097) | 2.63237785 |
| 46 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.63169555 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.60976041 |
| 48 | Abnormal biliary tract morphology (HP:0012440) | 2.60329621 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.57934932 |
| 50 | Abnormality of vitamin B metabolism (HP:0004340) | 2.56883806 |
| 51 | Curly hair (HP:0002212) | 2.55943121 |
| 52 | Stenosis of the external auditory canal (HP:0000402) | 2.54745755 |
| 53 | Abnormality of carpal bone ossification (HP:0006257) | 2.54525496 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.51833558 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.51833558 |
| 56 | Hypobetalipoproteinemia (HP:0003563) | 2.51505065 |
| 57 | Gastrointestinal dysmotility (HP:0002579) | 2.51298802 |
| 58 | Confusion (HP:0001289) | 2.51266747 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47974251 |
| 60 | Widely patent fontanelles and sutures (HP:0004492) | 2.46674892 |
| 61 | Acanthocytosis (HP:0001927) | 2.46575786 |
| 62 | Ventricular tachycardia (HP:0004756) | 2.45006622 |
| 63 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.42348447 |
| 64 | Congenital, generalized hypertrichosis (HP:0004540) | 2.39216181 |
| 65 | Hypophosphatemic rickets (HP:0004912) | 2.38687606 |
| 66 | Alveolar cell carcinoma (HP:0006519) | 2.37637797 |
| 67 | Milia (HP:0001056) | 2.36025478 |
| 68 | Nephrolithiasis (HP:0000787) | 2.35985887 |
| 69 | Micronodular cirrhosis (HP:0001413) | 2.32766771 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.30480467 |
| 71 | Biliary tract neoplasm (HP:0100574) | 2.25722689 |
| 72 | Hyperglycinemia (HP:0002154) | 2.25617132 |
| 73 | Abnormality of the gastric mucosa (HP:0004295) | 2.24682379 |
| 74 | Cheilitis (HP:0100825) | 2.24439657 |
| 75 | Toxemia of pregnancy (HP:0100603) | 2.23786995 |
| 76 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.23283275 |
| 77 | Pendular nystagmus (HP:0012043) | 2.23034590 |
| 78 | Renal tubular acidosis (HP:0001947) | 2.22815796 |
| 79 | Posterior subcapsular cataract (HP:0007787) | 2.20026199 |
| 80 | Chronic diarrhea (HP:0002028) | 2.19811116 |
| 81 | Thin bony cortex (HP:0002753) | 2.17982041 |
| 82 | Hyponatremia (HP:0002902) | 2.17845529 |
| 83 | Cerebral palsy (HP:0100021) | 2.17306585 |
| 84 | Achilles tendon contracture (HP:0001771) | 2.17172921 |
| 85 | Pili torti (HP:0003777) | 2.15949755 |
| 86 | Abnormality of the costochondral junction (HP:0000919) | 2.14381665 |
| 87 | Rhabdomyolysis (HP:0003201) | 2.14323431 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 2.09854231 |
| 89 | Metabolic acidosis (HP:0001942) | 2.09798689 |
| 90 | Hepatic necrosis (HP:0002605) | 2.09419949 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.09392228 |
| 92 | Polygenic inheritance (HP:0010982) | 2.08936327 |
| 93 | Glomerulosclerosis (HP:0000096) | 2.08559315 |
| 94 | Parakeratosis (HP:0001036) | 2.05394560 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.05375779 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.05375779 |
| 97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.04161336 |
| 98 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.04064972 |
| 99 | Plantar hyperkeratosis (HP:0007556) | 2.03778257 |
| 100 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.01729730 |
| 101 | Hypercholesterolemia (HP:0003124) | 2.01682756 |
| 102 | Abnormality of purine metabolism (HP:0004352) | 2.01309425 |
| 103 | Amelogenesis imperfecta (HP:0000705) | 2.01221998 |
| 104 | Difficulty running (HP:0009046) | 2.00908942 |
| 105 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00898617 |
| 106 | Protuberant abdomen (HP:0001538) | 2.00384174 |
| 107 | Hyperphosphaturia (HP:0003109) | 1.99638614 |
| 108 | Lethargy (HP:0001254) | 1.99130995 |
| 109 | Conjugated hyperbilirubinemia (HP:0002908) | 1.99118277 |
| 110 | Abnormality of vitamin metabolism (HP:0100508) | 1.98986614 |
| 111 | Syncope (HP:0001279) | 1.98775965 |
| 112 | Dicarboxylic aciduria (HP:0003215) | 1.98668119 |
| 113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98668119 |
| 114 | Esophageal varix (HP:0002040) | 1.98664770 |
| 115 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97652766 |
| 116 | Ridged nail (HP:0001807) | 1.97062066 |
| 117 | Type I diabetes mellitus (HP:0100651) | 1.96603634 |
| 118 | Exocrine pancreatic insufficiency (HP:0001738) | 1.96177738 |
| 119 | Fat malabsorption (HP:0002630) | 1.96088984 |
| 120 | Fragile skin (HP:0001030) | 1.96003027 |
| 121 | Increased purine levels (HP:0004368) | 1.95877524 |
| 122 | Hyperuricemia (HP:0002149) | 1.95877524 |
| 123 | Metaphyseal irregularity (HP:0003025) | 1.95149484 |
| 124 | Hepatocellular necrosis (HP:0001404) | 1.94896460 |
| 125 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.94562933 |
| 126 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.93733336 |
| 127 | Pterygium (HP:0001059) | 1.93100134 |
| 128 | Proximal tubulopathy (HP:0000114) | 1.91953590 |
| 129 | Sensorimotor neuropathy (HP:0007141) | 1.90602758 |
| 130 | Hyperglycemia (HP:0003074) | 1.89955389 |
| 131 | Atrophic scars (HP:0001075) | 1.89942579 |
| 132 | Paraparesis (HP:0002385) | 1.88992577 |
| 133 | Subcapsular cataract (HP:0000523) | 1.88123018 |
| 134 | Alkalosis (HP:0001948) | 1.87997029 |
| 135 | Termporal pattern (HP:0011008) | 1.87410244 |
| 136 | Insidious onset (HP:0003587) | 1.87410244 |
| 137 | Shawl scrotum (HP:0000049) | 1.87249569 |
| 138 | Generalized aminoaciduria (HP:0002909) | 1.86810408 |
| 139 | Hyperaldosteronism (HP:0000859) | 1.86335850 |
| 140 | Hyperphosphatemia (HP:0002905) | 1.86234827 |
| 141 | Petechiae (HP:0000967) | 1.86096763 |
| 142 | Abnormal ossification of hand bones (HP:0005921) | 1.86096572 |
| 143 | Palmar hyperkeratosis (HP:0010765) | 1.85917639 |
| 144 | Pancreatitis (HP:0001733) | 1.84605641 |
| 145 | Abnormal urine phosphate concentration (HP:0012599) | 1.82635617 |
| 146 | Neoplasm of the rectum (HP:0100743) | 1.82298076 |
| 147 | Ventricular arrhythmia (HP:0004308) | 1.81628736 |
| 148 | Progressive sensorineural hearing impairment (HP:0000408) | 1.81197967 |
| 149 | Myoglobinuria (HP:0002913) | 1.81060191 |
| 150 | Ventricular fibrillation (HP:0001663) | 1.80859764 |
| 151 | Glycosuria (HP:0003076) | 1.77225162 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.77225162 |
| 153 | Abnormal hand bone ossification (HP:0010660) | 1.76160763 |
| 154 | Abnormality of the prostate (HP:0008775) | 1.75153402 |
| 155 | Nausea (HP:0002018) | 1.73692428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CA | 8.14172809 |
| 2 | MST1R | 7.92383626 |
| 3 | MAP3K2 | 4.42268939 |
| 4 | LMTK2 | 3.93604046 |
| 5 | KSR2 | 3.63177632 |
| 6 | MAP2K2 | 3.53204934 |
| 7 | ACVR1B | 3.11133451 |
| 8 | MET | 2.86166190 |
| 9 | EPHB2 | 2.72666765 |
| 10 | PRKG2 | 2.27717923 |
| 11 | MYLK | 2.18025813 |
| 12 | STK24 | 2.04570255 |
| 13 | MST4 | 1.91162866 |
| 14 | NME1 | 1.89787878 |
| 15 | PBK | 1.87906768 |
| 16 | NEK1 | 1.73815532 |
| 17 | TTK | 1.65626434 |
| 18 | MAP2K1 | 1.63120773 |
| 19 | OXSR1 | 1.58116924 |
| 20 | CAMK2D | 1.52222065 |
| 21 | GRK1 | 1.49795649 |
| 22 | FRK | 1.48132291 |
| 23 | TESK1 | 1.47644825 |
| 24 | EPHA2 | 1.40410205 |
| 25 | PDK2 | 1.40387345 |
| 26 | TESK2 | 1.38748588 |
| 27 | PAK4 | 1.33951463 |
| 28 | MAP3K3 | 1.29456805 |
| 29 | ERBB4 | 1.16668092 |
| 30 | ADRBK2 | 1.06034615 |
| 31 | TYK2 | 1.04111408 |
| 32 | MAP3K1 | 1.02799898 |
| 33 | GRK6 | 0.97472014 |
| 34 | SIK1 | 0.93573593 |
| 35 | NME2 | 0.92633785 |
| 36 | MAP3K8 | 0.87931914 |
| 37 | AKT3 | 0.86969111 |
| 38 | TAOK3 | 0.86774611 |
| 39 | RIPK4 | 0.85510629 |
| 40 | EIF2AK1 | 0.85509803 |
| 41 | CDK19 | 0.83643272 |
| 42 | DMPK | 0.80861769 |
| 43 | RPS6KB2 | 0.79302523 |
| 44 | DDR2 | 0.76242361 |
| 45 | ADRBK1 | 0.71772183 |
| 46 | BRSK2 | 0.69420722 |
| 47 | LIMK1 | 0.67954142 |
| 48 | NUAK1 | 0.67188855 |
| 49 | BRAF | 0.65755118 |
| 50 | PKN2 | 0.65680919 |
| 51 | ABL2 | 0.65148029 |
| 52 | TRIB3 | 0.64934442 |
| 53 | RET | 0.64664049 |
| 54 | EPHB1 | 0.64083622 |
| 55 | STK38L | 0.63790161 |
| 56 | MATK | 0.63008431 |
| 57 | ARAF | 0.60065982 |
| 58 | PDPK1 | 0.59766830 |
| 59 | PTK6 | 0.59449175 |
| 60 | CLK1 | 0.59258456 |
| 61 | MAP3K14 | 0.58833663 |
| 62 | IRAK3 | 0.58590763 |
| 63 | MAPKAPK2 | 0.57715184 |
| 64 | CAMK2G | 0.57464747 |
| 65 | EIF2AK3 | 0.57402100 |
| 66 | WNK1 | 0.55330310 |
| 67 | CAMK2B | 0.54871563 |
| 68 | DAPK3 | 0.54297467 |
| 69 | PRKD3 | 0.52746440 |
| 70 | PRKCI | 0.51856314 |
| 71 | TIE1 | 0.49820296 |
| 72 | BMX | 0.47689156 |
| 73 | CDK9 | 0.45861451 |
| 74 | PTK2 | 0.45781197 |
| 75 | EEF2K | 0.45741058 |
| 76 | FER | 0.42124995 |
| 77 | BCKDK | 0.40940338 |
| 78 | LRRK2 | 0.40848732 |
| 79 | RIPK1 | 0.39999467 |
| 80 | TAOK1 | 0.39930001 |
| 81 | MAP3K9 | 0.39850067 |
| 82 | PAK2 | 0.39322079 |
| 83 | SRC | 0.37400467 |
| 84 | ILK | 0.37096946 |
| 85 | MAPK15 | 0.37096545 |
| 86 | CSK | 0.36715659 |
| 87 | ALK | 0.36370807 |
| 88 | STK3 | 0.35547435 |
| 89 | TBK1 | 0.35114285 |
| 90 | MAP3K11 | 0.35074206 |
| 91 | PIK3CG | 0.34543000 |
| 92 | BCR | 0.33999942 |
| 93 | EPHA3 | 0.33518265 |
| 94 | DAPK1 | 0.31741761 |
| 95 | PDK1 | 0.31154303 |
| 96 | STK10 | 0.30649919 |
| 97 | MAP3K12 | 0.30350797 |
| 98 | PTK2B | 0.29846683 |
| 99 | PRKCA | 0.29531474 |
| 100 | ROCK1 | 0.28030186 |
| 101 | AURKB | 0.25084044 |
| 102 | CDK8 | 0.24430541 |
| 103 | MELK | 0.24236916 |
| 104 | ERN1 | 0.22767266 |
| 105 | TAOK2 | 0.22558809 |
| 106 | ITK | 0.22324027 |
| 107 | PAK1 | 0.21822427 |
| 108 | GSK3A | 0.21504404 |
| 109 | SIK3 | 0.20367138 |
| 110 | PRKD2 | 0.19887963 |
| 111 | MAP3K13 | 0.19720000 |
| 112 | JAK2 | 0.19604610 |
| 113 | PIM2 | 0.19600009 |
| 114 | MAPK4 | 0.19559240 |
| 115 | STK39 | 0.19556537 |
| 116 | FYN | 0.19414057 |
| 117 | ERBB2 | 0.19108937 |
| 118 | BUB1 | 0.19014676 |
| 119 | CDK3 | 0.17794437 |
| 120 | IGF1R | 0.17353375 |
| 121 | CDC42BPA | 0.17255347 |
| 122 | CSNK1E | 0.16771289 |
| 123 | MAP3K10 | 0.15940758 |
| 124 | PRKCQ | 0.15471896 |
| 125 | GRK5 | 0.14571486 |
| 126 | DYRK3 | 0.13213319 |
| 127 | KDR | 0.12580208 |
| 128 | PRKACG | 0.12240036 |
| 129 | MAP2K6 | 0.11393394 |
| 130 | LYN | 0.10932688 |
| 131 | RPS6KA5 | 0.10733277 |
| 132 | PRKCB | 0.10324672 |
| 133 | CSNK2A2 | 0.10159965 |
| 134 | MAPK7 | 0.10157821 |
| 135 | PRKCH | 0.09825713 |
| 136 | TTN | 0.09724939 |
| 137 | PRKCE | 0.09548556 |
| 138 | PRKAA2 | 0.07230111 |
| 139 | TNIK | 0.07213190 |
| 140 | FGFR4 | 0.07078618 |
| 141 | CSNK1A1 | 0.06243896 |
| 142 | PRKCD | 0.06199207 |
| 143 | CAMK2A | 0.05159444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.75923494 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 4.14837376 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.05622576 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.57665808 |
| 5 | Bile secretion_Homo sapiens_hsa04976 | 2.57222591 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.54094537 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.35769702 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.33586651 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.31053331 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.20441920 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.12664266 |
| 12 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.05871345 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 1.89820245 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89742749 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.79487323 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.76644912 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.68814168 |
| 18 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.65815279 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64513093 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53029234 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.52452155 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.50267624 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.49035290 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44502602 |
| 25 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.43739079 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.42185747 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38431983 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35936707 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33544492 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.29232230 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29093479 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26116060 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24858104 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24566355 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23784194 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.22525891 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20735514 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17237982 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 1.11907885 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10330125 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.10187185 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08653374 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08541955 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08487901 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04789047 |
| 46 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03211920 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02344145 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00675983 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99998105 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99784510 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98822959 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.95985242 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.92998410 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89675819 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.89002844 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88372685 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85646249 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85608252 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.83432154 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76104075 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74656153 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73322095 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72866789 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72478739 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71053185 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70557561 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70183261 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69531645 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.67334878 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66971781 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65572035 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64530839 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62831792 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61189863 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60799923 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59648020 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58165220 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57012847 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55953212 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55101315 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53245576 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51702853 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.49301955 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47115350 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46579632 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45609065 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43259666 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43030735 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40599881 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.40180859 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.38966131 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38811834 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37446063 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.36914999 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36640454 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34460718 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34143300 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32712890 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30628458 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29904350 |
| 101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27259592 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27252657 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25988515 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25272494 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25013133 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24359969 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22242775 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22070578 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21367312 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.19327427 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.18333465 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16498484 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.16182927 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14698552 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.13660321 |
| 116 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.13531279 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.13240316 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.12559163 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11713295 |
| 120 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.10667863 |
| 121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.09166714 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07171243 |
| 123 | Phototransduction_Homo sapiens_hsa04744 | 0.07002551 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.01061303 |

